PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Imperial College London, London, UK.\', \'School of Public Health, Imperial College London, London, UK.\', \'Abadan Faculty of Medical Sciences, Abadan, Iran.\', \'Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Pharmacy, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Gut and Liver Research Centre, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Department of Translational Medicine, University of Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkaa418
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33063117
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33063117>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33063117>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all